Oncomine Comprehensive Panel Oncomine Tumor Mutation Burden TMB MSI PDL1
Introduction to the Test
The Oncomine Comprehensive Panel is a cutting-edge diagnostic test that plays a pivotal role in the field of oncology. This test assesses tumor mutation burden (TMB), microsatellite instability (MSI), and PDL1 expression, providing oncologists with vital information for personalized cancer treatment. Understanding the genetic makeup of a tumor is essential for developing tailored therapies that can significantly improve patient outcomes.
What the Test Measures
The Oncomine Comprehensive Panel detects:
- Tumor Mutation Burden (TMB): This measures the number of mutations within the tumor’s DNA, which can indicate how well a tumor might respond to immunotherapy.
- Microsatellite Instability (MSI): This assesses the stability of the tumor’s DNA, helping to identify patients who may benefit from specific immunotherapies.
- PDL1 Expression: This evaluates the presence of PDL1 protein on tumor cells, which is crucial for determining the suitability of certain immuno-oncology treatments.
Who Should Consider This Test?
This test is recommended for patients with:
- Advanced cancer seeking personalized treatment options.
- Family history of cancer or genetic predispositions.
- Symptoms indicating possible malignancies.
- Patients who have undergone previous cancer treatments and are considering new therapies.
Benefits of Taking the Test
The Oncomine Comprehensive Panel offers several benefits:
- Provides comprehensive insights into the tumor’s genetic profile.
- Facilitates personalized treatment plans based on individual tumor characteristics.
- Helps oncologists predict the likelihood of response to specific therapies.
- Can guide decisions on clinical trial eligibility for novel therapies.
Understanding Your Results
Results from the Oncomine Comprehensive Panel will provide detailed information about the tumor’s genetic characteristics. It is essential to discuss these results with your oncologist, who can interpret them in the context of your overall health and treatment options. Each patient’s results are unique, and your doctor will help you understand what they mean for your specific situation.
Test Details and Pricing
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| Oncomine Comprehensive Panel Oncomine Tumor Mutation Burden TMB MSI PDL1 | 2400000 | 3200000 |
Booking the Test
To book the Oncomine Comprehensive Panel test, please ensure you have a doctor’s prescription, as it is required for the test. Note that this prescription is not applicable for surgery and pregnancy cases or for individuals planning to travel abroad. For more information or to schedule your test, contact us via phone or WhatsApp at +2348077798758.
Turnaround Time and Sample Type
The test has a turnaround time of 2-3 weeks and requires a sample of tumor tissue along with peripheral blood. The sample should include paraffin-embedded tissue blocks and an EDTA Vacutainer (3 ml).
Invest in your health today by understanding your cancer better with the Oncomine Comprehensive Panel.
